Progress Towards a Therapeutic HIV DNA Vaccine

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Antiretroviral therapy (ART) manages HIV but does not cure it, necessitating research into functional cures.
• Therapeutic vaccines seek to induce potent HIV-specific immunity for viral load control without lifelong ART.
• DNA vaccines offer advantages for HIV therapeutic vaccine development due to ease of manufacturing and induction of cellular and antibody responses.

Purpose of the Study:

• To review progress in therapeutic HIV DNA vaccine development.
• To highlight innovations in vaccine delivery to enhance immunogenicity.
• To identify barriers and explore complementary strategies for effective therapeutic HIV DNA vaccines.

Main Methods:

• Review of current research on therapeutic HIV DNA vaccines.
• Analysis of advancements in vaccine delivery systems (e.g., skin vs. muscle targeting).
• Exploration of complementary therapeutic approaches to enhance DNA vaccine efficacy.

Main Results:

• Significant progress has been made in therapeutic HIV DNA vaccine research.
• Delivery innovations are shifting from intramuscular injection to skin-based delivery and enhanced transfection.
• Combining DNA vaccines with other strategies remains an underdeveloped but promising area.

Conclusions:

• Therapeutic HIV DNA vaccines hold promise for achieving a functional cure.
• Optimizing delivery methods and exploring combination therapies are crucial for overcoming existing barriers.
• Further research into novel delivery systems and complementary approaches is essential for advancing HIV functional cure strategies.